Drugmakers Throw ‘Kitchen Sink’ to Halt Medicare Price Negotiationsnews2023-07-23T07:00:18+00:00July 23rd, 2023|The New York Times|
Leqembi: lo que hay que saber sobre el fármaco contra el alzhéimernews2023-07-08T11:00:12+00:00July 8th, 2023|The New York Times|
What to Know About Leqembi, the Alzheimer’s Drug Approved by the FDAnews2023-07-06T22:20:07+00:00July 6th, 2023|The New York Times|
FDA Makes Alzheimer’s Drug Leqembi Widely Accessiblenews2023-07-06T21:26:16+00:00July 6th, 2023|The New York Times|
Retiree Medical Costs Expected to Stay Flat in 2023news2023-06-30T13:00:17+00:00June 30th, 2023|The New York Times|
Merck Sues Over Medicare Drug-Price Negotiation Lawnews2023-06-06T18:41:33+00:00June 6th, 2023|The New York Times|
Addiction Treatment Medicine Is Vastly Underprescribed, Especially by Race, Study Findsnews2023-05-10T21:49:51+00:00May 10th, 2023|The New York Times|
Biden Looks to Bolster Support Among Seniors With a Focus on Health Carenews2023-03-15T21:13:33+00:00March 15th, 2023|The New York Times|
Joe Biden: My Plan to Extend Medicare for Another Generationnews2023-03-07T20:08:33+00:00March 7th, 2023|The New York Times|
The Medicine Is a Miracle, but Only if You Can Afford Itnews2023-02-07T14:47:34+00:00February 7th, 2023|The New York Times|
